ESPERITE
ESPERITE
Open: -
Change: -
Volume: -
Low: -
High: -
High / Low range: -
Type: Stocks
Ticker: ESP
ISIN: NL0009272137

ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018

  • 107

Amsterdam, The Netherlands - 19 November 2018

Esperite announces that the preparation of its Annual Report 2017 is now under final review by its auditors and should be published before 24 November 2018.

About ESPERITE
ESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and precision medicine founded in 2000.
To learn more about the ESPERITE Group, or to book an interview with CEO Frédéric Amar: +31 575 548 998 - [email protected] or visit the websites at www.esperite.comwww.genoma.com and www.cryo-save.com.

***

This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).




This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Esperite N.V. via Globenewswire

GlobeNewsWire Europe
GlobeNewsWire Europe

GlobeNewswire Europe, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.